Speaker

Johanna Olweus earned her MD degree in 1992 and obtained her PhD with a thesis focused on hematopoietic stem cell biology in 1998, at the University of Bergen, Norway. Following clinical training resulting in specialization in Immunology and Transfusion Medicine (Clinical Immunology) in 2006 in Oslo, Norway, she built up a research group focused on studies of T cell-based cancer immunotherapy. As Director for K.G. Jebsen Center for Cancer Immunotherapy she led the center through two terms (2013-2020, with max. prolongation). Since 2008 she holds the position as Head of Department of Cancer Immunology, Institute for Cancer Research at the OECI-accredited Comprehensive Cancer Center of Oslo University Hospital, and Professor at the University of Oslo. Her training in transplantation immunology inspired her to work towards the following goal: to utilize the powerful immune responses of graft-versus-tumor-reactivity and graft rejection to reject cancer cells in a specific and controlled manner. In 2019 she got an ERC Consolidator grant to pursue this goal.

« Go Back